Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,96 USD | -1,00% | -5,73% | -52,83% |
Omzet 2022 | 22,3 mln. 20,94 mln. | Omzet 2023 | 7,19 mln. 6,75 mln. | Marktkapitalisatie | 25,42 mln. 23,86 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -62 mln. -58,2 mln. | Nettowinst (verlies) 2023 | -50 mln. -46,94 mln. | EV/omzet 2022 | 2,66 x |
Nettoschuld 2022 | 48,89 mln. 45,89 mln. | Nettoschuld 2023 | 33,81 mln. 31,74 mln. | EV/omzet 2023 | 8,23 x |
K/w-verhouding 2022 |
-0,12
x | K/w-verhouding 2023 |
-0,33
x | Werknemers | 113 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 18,78% |
Recentste transcriptie over T2 Biosystems, Inc.
1 dag | -1,00% | ||
1 week | -5,73% | ||
Lopende maand | -1,33% | ||
1 maand | -15,19% | ||
3 maanden | -32,73% | ||
6 maanden | -47,75% | ||
Lopend jaar | -52,83% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John Sperzel
CEO | Chief Executive Officer | 60 | 08-01-20 |
John Sprague
DFI | Director of Finance/CFO | 65 | 30-01-18 |
Roger Smith
CTO | Chief Tech/Sci/R&D Officer | 59 | 01-01-14 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Elsbree
BRD | Director/Board Member | 76 | 01-07-14 |
Seymour Liebman
BRD | Director/Board Member | 74 | 21-09-16 |
Robin Toft
BRD | Director/Board Member | 63 | 14-06-20 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
19-04-24 | 2,96 | -1,00% | 439 490 |
18-04-24 | 2,99 | +1,70% | 106 827 |
17-04-24 | 2,94 | -2,97% | 63 952 |
16-04-24 | 3,03 | +2,02% | 84 568 |
15-04-24 | 2,97 | -5,41% | 188 846 |
uitgestelde koers Nasdaq, 19 april 2024 om 22:00 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-52,83% | 16,48 mln. | |
+2,64% | 207 mld. | |
+1,80% | 175 mld. | |
+8,59% | 132 mld. | |
+16,47% | 99,1 mld. | |
-3,42% | 60,89 mld. | |
+12,71% | 52,04 mld. | |
-6,61% | 45,48 mld. | |
-4,53% | 38,81 mld. | |
+9,27% | 38,77 mld. |